Sean Nolan as vice president and chief commercial officer...Vanda Pharmaceuticals Inc., of Rockville, Md., named Bob Repella senior vice president and chief commercial officer

Medivir AB, of Huddinge, Sweden, made several recent appointments, including Maris Hartmanis as deputy CEO and chief operating officer...Onyx Pharmaceuticals Inc., of South San Francisco, appointed Helen Torley executive vice president and chief commercial officer

Actelion Ltd., of Allschwil, Switzerland, nominated Jean-Pierre Garnier and Robert Bertolini to its board...Avanir Pharmaceuticals Inc., of Aliso Viejo, Calif., appointed William (Bill) Sibold senior vice president and chief commercial officer

Addex Pharmaceuticals Ltd., of Geneva, proposed adding Hoyoung Huh and Oleg Nodelman to the board...Affimed Therapeutics AG, of Heidelberg, Germany, appointed Adi Hoess chief commercial officer

Medgenics Inc., of Misgav, Israel, added Isaac Blech and Raymond Dean Hautamaki to its board...Mitomics, of Thunder Bay, Ontario, added Luis Martin as chief commercial officer and named Stephen S. Galliker to its board

Oncos Therapeutics, of Helsinki, Finland, appointed Jonathan Knowles and Robert Burns to its board...Trius Therapeutics Inc., of San Diego, appointed J. Craig Thompson chief commercial officer

plc, of Dublin, Ireland, named Paul E. Huff chief commercial officer...The firm also named Lori M. Henderson vice president, general counsel and secretary

Oligomerix Inc., of New York, appointed Vic Micati chairman and named Jack Pasini chief commercial officer and board member

Predictive Biosciences Inc., of Lexington, Mass., appointed Thomas M. Ross chief commercial officer and named Randal Vader vice president of clinical and regulatory affairs...Regenicin Inc., of New York, added Joseph Rubinfeld and Craig Eagle to its board

HemoShear LLC, of Charlottesville, Va., added Robert Ruffolo and Kenneth Batchelor to its scientific advisory board...Horizon Discovery Ltd., of Cambridge, UK, appointed Nigel Pitchford and David Evans to its board...NeoStem Inc., of New York, appointed Ian Zhang president and managing director of NeoStem (China) Inc

Aegerion Pharmaceuticals Inc., of Bridgewater, N.J., named Marc Beer CEO and board member...AVEO Pharmaceuticals Inc., of Cambridge, Mass., appointed Michael P. Bailey chief commercial officer and Donna M. Radzik vice president of technical operations

Spectrum Pharmaceuticals Inc., of Irvine, Calif., appointed James E. Shields senior vice president and chief commercial officer...Spencer Pharmaceutical Inc., of Boston, named Max Arella president and chairman

Ablexis LLC, of San Francisco, appointed Scott Greer chairman and named Richard Hoffman chief business officer...BioVex Inc., of Woburn, Mass., appointed Steven Kelly chief commercial officer

AMAG Pharmaceuticals Inc., of Lexington, Mass., named Gary J. Zieziula executive vice president and chief commercial officer...Vivus Inc., of Mountain View, Calif., named Michael P. Miller senior vice president and chief commercial officer

AMAG Pharmaceuticals Inc., of Lexington, Mass., appointed Gary J. Zieziula executive vice president and chief commercial officer...CMDBioscience, of Orange, Conn., appointed Erick Suchanek and Bernhardt Trout to its scientific advisory board

Affymetrix Inc., of Santa Clara, Calif., added Andrew J. Last as chief commercial officer...Anesiva Inc., of South San Francisco, named Ted W. Love and David C. U'Prichard to its board, following completion of the merger with Arcion Therapeutics

Ironwood Pharmaceuticals Inc., of Cambridge, Mass., named Thomas McCourt chief commercial officer and senior vice president of marketing and sales, and appointed David Ebersman to its board

Orexigen Therapeutics Inc., of San Diego, named Mark Booth chief commercial officer...PharmAthene Inc., of Annapolis, Md., appointed Charles A. Reinhart III senior vice president and chief financial officer

Xanodyne Pharmaceuticals Inc., of Newport, Ken, appointed Natasha Giordano as chief commercial officer, Rita O'Connor as chief financial & information officer, and Peter Wentworth as senior vice president for human resources